Title: COVID-19 HRSA Claims Reimbursement for the Uninsured Program
Accounting Policies: The accompanying schedule of expenditures of federal awards (the Schedule) presents the federal grant activity of Flushing Hospital Medical Center and its subsidiary (Flushing). The information in the Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). The purpose of the Schedule is to present a summary of those activities of Flushing for the year ended December 31, 2022 which have been financed by the federal government. For purposes of the Schedule, federal awards include any assistance provided by a federal agency directly or indirectly in the form of loans or grants, contracts, cooperative agreements, loans and loan guarantees, and other noncash assistance. Where available, passthrough entity identifying numbers are included in the Schedule. Because the Schedule presents only a selected portion of the activities of Flushing, it is not intended to and does not present either the financial position or the revenues, expenditures, and other changes in net deficit of Flushing. Therefore, some amounts presented in this schedule may differ from amounts presented in, or used in, the preparation of Flushings consolidated financial statements.Expenditures for direct costs within the Schedule are recognized using the accrual method of accounting and in accordance with The Department of Health and Human Services, U.S. Office of the Assistant Secretary Comptroller (OASC) OASC3, A Guide for Hospitals. Under those cost principles, certain types of expenditures are not allowable or are limited as to reimbursement. Flushing applies the indirect cost rate approved by the granting agency at the time of the award rather than the 10% de minimis indirect cost rate as described in Section 200.414 of the Uniform Guidance.
De Minimis Rate Used: N
Rate Explanation: Flushing applies the indirect cost rate approved by the granting agency at the time of the award rather than the 10% de minimis indirect cost rate as described in Section 200.414 of the Uniform Guidance.
Flushing conducted COVID-19 testing and/or provided treatment for uninsured individuals with a COVID-19 primary diagnosis and requested claims reimbursement under the U.S. Department of Health and Human Services (HHS) Health Resources and Services Administration's ("HRSA") COVID-19 Claims Reimbursement for the Uninsured Program (Assistance Listing Number 93.461) through the end of the award period in 2022. Claims for testing and treatment were accepted through March 22, 2022 and claims for vaccine administration were accepted through April 5, 2022.The amount recorded on the Schedule reflects reimbursement on eligible claims with through the end of the award period.
Title: COVID-19 Provider Relief Fund and American Rescue Plan (ARP) Rural Distr
Accounting Policies: The accompanying schedule of expenditures of federal awards (the Schedule) presents the federal grant activity of Flushing Hospital Medical Center and its subsidiary (Flushing). The information in the Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). The purpose of the Schedule is to present a summary of those activities of Flushing for the year ended December 31, 2022 which have been financed by the federal government. For purposes of the Schedule, federal awards include any assistance provided by a federal agency directly or indirectly in the form of loans or grants, contracts, cooperative agreements, loans and loan guarantees, and other noncash assistance. Where available, passthrough entity identifying numbers are included in the Schedule. Because the Schedule presents only a selected portion of the activities of Flushing, it is not intended to and does not present either the financial position or the revenues, expenditures, and other changes in net deficit of Flushing. Therefore, some amounts presented in this schedule may differ from amounts presented in, or used in, the preparation of Flushings consolidated financial statements.Expenditures for direct costs within the Schedule are recognized using the accrual method of accounting and in accordance with The Department of Health and Human Services, U.S. Office of the Assistant Secretary Comptroller (OASC) OASC3, A Guide for Hospitals. Under those cost principles, certain types of expenditures are not allowable or are limited as to reimbursement. Flushing applies the indirect cost rate approved by the granting agency at the time of the award rather than the 10% de minimis indirect cost rate as described in Section 200.414 of the Uniform Guidance.
De Minimis Rate Used: N
Rate Explanation: Flushing applies the indirect cost rate approved by the granting agency at the time of the award rather than the 10% de minimis indirect cost rate as described in Section 200.414 of the Uniform Guidance.
During the years ended December 31, 2021 and 2020, Flushing received Provider Relief Funds (PRF) under Assistance Listing Number 93.498 from HHS, as further described in Note 13 to the consolidated financial statements. Pursuant to the guidance provided by HHS, the Schedule includes all Period 4 funds received between July 1, 2021 and December 31, 2021 and expended by December 31, 2022 as reported to HRSA via the PRF Reporting Portal.Flushing did not receive any Period 3 funds between January 1, 2021 and June 30, 2021.